Abstract
Introduction

Hepatocellular carcinoma (HCC) is one of most prevalent primary cancers of the liver worldwide, and is known to arise almost exclusively under certain established high-risk situations. A number of major risk factors for the development of HCC have been recognized, including hepatitis B and C viral infection, chronic alcoholic abuse, liver cirrhosis from almost any etiology and rare environmental factors, such as repeated exposure to aflatoxin (1, 2). The incidence of HCC without the above circumstances is uncommon; however, HCC can occasionally develop in the healthy liver during normal aging (1). In the present patient, HCC occurred sequentially over a short period in the liver without any known risk factors for HCC, except for long-standing Crohn's disease (CD). CD is a chronic inflammatory disease that can affect any region of the gastrointestinal tract and is also considered a systemic disorder that often involves other organs (3). In addition, the association between CD and various cancers, especially small intestinal and colorectal carcinoma, has been demonstrated
, and reports dealing with CD and HCC have also been documented (6) (7) (8) (9) (10) F i g u r e 1 . Ab d o mi n a l e n h a n c e d CT i ma g i n g wi t h c o n t r a s t me d i u m i n Ma r c h 2 0 0 7 . He p a t i c n o d u l e s l o c a t e d i n s e g me n t VI a n d VI I we r e v i s u a l i z e d , s h o wi n g e a r l y a r t e r i a l e n h a n c e me n t a n d a h o mo g e n e o u s d e f e c t i n t h e d e l a y e d p o r t a l p h a s e s u g g e s t i n g HCC ( F i g . 1 a , 1 b ) . S p l e n o me g a l y , a d u l l e d g e o f t h e l i v e r a n d g a l l s t o n e s we r e s e e n ; h o we v e r , h e p a t i c p a r e n c h y ma o t h e r t h a n n o d u l a r l e s i o n s a p p e a r e d a l mo s t n o r ma l . (Fig. 1a, 1b) . The remaining hepatic parenchyma appeared otherwise almost normal, although a dull edge of the liver and splenomegaly were demonstrated, suggesting the presence of some chronic change (Fig. 1a) Hi s t o p a t h o l o g i c a l e x a mi n a t i o n o f t i s s u e s o b t a i n e d f r o m b o t h t u mo r s a n d n o n -t Hi s t o p a t h o l o g y o f t h e t i s s u e s t a k e n f r o m t h e t u mo r i n s e gme n t VI I b y f i n e n e e d l e a s p i r a t i o n b i o p s y d i s c l o s e d we l l -d i f f e r e n t i a t e d HCC wi t h a h i g h N/ C r a t i o  s h o wi n g t r a b e c u l a r s t r u c t u r e s a d j a c e n t t o n o r ma l h e p a t o c y t e s ( He ma t o x y l i n a n d E o s i n s t a i n i n g )  ( F i g . 2 a ) . On t h e o t h e r h a n d , mi c r o s c o p i c f i n d i n g s o f t h e n o n -t u mo r r e g i o n n e i g h b o r i n g b u t r 
e mo t e f r o m t h e t u mo r o b t a i n e d r a n d o ml y b y c o r e b i o p s y r e v e a l e d t o t a l l y we l l -p r e s e r v e d h e p a t i c p a r e nc h y ma ; h o we v e r , mo n o n u c l e a r c e l l i n f i l t r a t i o n a n d f i b r o s i s i n t h e p o r t a l a r e a s u g g e s t i n g s o me c h r o n i c l i v e r i n f l a mma t i o n we r e o b s e r v e d ( Ma s s o n t r i c h r o me s t a i n i n g ) ( F i g . 2 b ) . b a
F i g u r e 3 . Ab d o mi n a l a n g i o g r a p h y r e v e a l e d a d d i t i o n a l h y p e r v a s c u l a r t u mo r s t a i n s o t h e r t h a n t h e o r i g i n a l l y d e t e c t e d n o d u l e s ; t h e r e f o r e , t r a n s c a t h e t e r a r t e r i a l c h e mo e mb o l i z a t i o n ( T ACE ) wa s c a r r i e d o u t a c c o r d i n g t o t h e g u i d e l i n e s f o r t h e t r e a t me n t o f HCC i n J a p a n . T h e a r c h i t e c t u r e o f i n t r a h e p a t i c a r t e r i e s wa s d i s t o r t e d b y h e p a t i c s u b c a p s u l a r h e ma t o ma .
however, mild mononuclear cell infiltration and fibrosis in the portal area were seen, suggesting some chronic liver inflammation (Fig. 2b) (Fig. 3) (14, 15) . Upon MRCP imaging, however, the present patient was not complicated T a b l e 1 . Cl i n i c a l B a c k g r o u n d o f Ca s e s o f HCC Ar i s i n g i n CD with PSC. Five other reports have dealt with CD patients who developed HCC without any established risk factors for HCC (6) (7) (8) (9) (10) (16, 17) ; in addition, HCC cases in renal transplant patients without apparent risk factors other than long-standing AZA therapy have been published (18) . The mechanisms by which patients treated with AZA are predisposed to malignancy are thought to be direct toxicity and mutagenic effects, enhanced susceptibility to oncogenic viruses and decreased immunological surveillance for neoplasms (19) . As for HCC presumably related to AZA, some reports have described that focal hepatic glycogenosis (FHG) played a preneoplastic role in the development of HCC (7, 9) , whereas there are other reports of IBD patients treated with AZA that failed to detect an increased risk of malignancy (11, 12 (20, 21) , however, half of the remaining HCC cases are of unknown origin (21) , and HCC can arise even in normal liver (1, 22) . In addition, regardless of risk, the rates of HCC increase progressively with aging (2) 
Discussion
This case report presents important clinical issues when dealing with patients with long-standing CD; that is, HCC can occur in patients with long disease history of CD, even without underlying high-risk liver diseases for HCC or a history of using immunosuppressant agents. CD is a chronic inflammatory disease that can affect any region of the gastrointestinal tract and is also considered a systemic disorder that often involves other organs (3). In addition, the close link between CD and malignancy, especially small intestinal and colorectal carcinoma, has been demonstrated (4, 5). When HCC becomes a problem during the course of CD, it is in the clinical setting that CD is found to be complicated by primary sclerosing cholangitis (PSC) (13). PSC is a chronic cholestatic liver condition of unknown etiology resulting in biliary cirrhosis, often requiring liver transplantation, and is known to occur frequently in association with inflammatory bowel diseases (IBD). Hitherto, two reports on HCC arising in CD patients in the presence of PSC have been described
